NO20065858L - Karboranylforfyriner og anvendelser derav - Google Patents

Karboranylforfyriner og anvendelser derav

Info

Publication number
NO20065858L
NO20065858L NO20065858A NO20065858A NO20065858L NO 20065858 L NO20065858 L NO 20065858L NO 20065858 A NO20065858 A NO 20065858A NO 20065858 A NO20065858 A NO 20065858A NO 20065858 L NO20065858 L NO 20065858L
Authority
NO
Norway
Prior art keywords
compounds
tetrafenylporphyrin
carborane
diagnosis
treatment
Prior art date
Application number
NO20065858A
Other languages
English (en)
Norwegian (no)
Inventor
Michiko Miura
Haitao Wu
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of NO20065858L publication Critical patent/NO20065858L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009—Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095—Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO20065858A 2004-05-20 2006-12-15 Karboranylforfyriner og anvendelser derav NO20065858L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/848,741 US6995260B2 (en) 2004-05-20 2004-05-20 Carboranylporphyrins and uses thereof
PCT/US2005/017358 WO2006088476A2 (en) 2004-05-20 2005-05-17 Carboranylporphyrins and uses thereof

Publications (1)

Publication Number Publication Date
NO20065858L true NO20065858L (no) 2007-02-09

Family

ID=35375345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065858A NO20065858L (no) 2004-05-20 2006-12-15 Karboranylforfyriner og anvendelser derav

Country Status (11)

Country Link
US (1) US6995260B2 (enExample)
EP (1) EP1753468A4 (enExample)
JP (1) JP2008505983A (enExample)
KR (1) KR20070026552A (enExample)
CN (1) CN1968705A (enExample)
AU (1) AU2005327597B2 (enExample)
CA (1) CA2567468A1 (enExample)
IL (1) IL179497A0 (enExample)
NO (1) NO20065858L (enExample)
NZ (1) NZ551732A (enExample)
WO (1) WO2006088476A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
US20070093463A1 (en) * 2004-05-20 2007-04-26 Brookhaven Science Associates, Llc Radiation enhancement agent for X-ray radiation therapy and boron neutron-capture therapy
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
GB0427589D0 (en) 2004-12-16 2005-01-19 Psimei Pharmaceuticals Plc Process for the preparation of a substituted porphyrin
US8287839B2 (en) * 2006-12-04 2012-10-16 Brookhaven Science Associates, Llc Carboranylporphyrins and uses thereof
WO2008102669A1 (ja) * 2007-02-19 2008-08-28 Rei Medical Co., Ltd. 新規な糖連結クロリン誘導体及びその製造方法
US8444953B2 (en) * 2007-03-22 2013-05-21 Brookhaven Science Associates, Llc Symmetric and asymmetric halogen-containing metallocarboranylporphyrins and uses thereof
US20080279781A1 (en) * 2007-05-10 2008-11-13 Brookhaven Science Associates, Llc Glycosylated Carboranylporphyrins and Uses Thereof
JP5745415B2 (ja) * 2009-09-17 2015-07-08 国立大学法人九州大学 ポルフィリン化合物
WO2011050575A1 (en) * 2009-10-28 2011-05-05 The University Of Hong Kong Hydroxy-substituted gold(iii) porphyrin complexes as histone deacetylase inhibitors
CN102268003B (zh) * 2011-06-16 2013-10-30 扬州大学 不对称多取代卟啉金(iii)类抗癌化合物及其制备方法
GB201221125D0 (en) * 2012-11-23 2013-01-09 Morex Dev Partners Llp Pharmaceutial formulations
KR102885276B1 (ko) * 2021-07-13 2025-11-11 삼성에스디아이 주식회사 염료, 이를 포함하는 조성물, 필름, 광학 부재 및 디스플레이 장치
CN114015066B (zh) * 2021-11-12 2022-08-12 北京大学 共价有机框架材料、其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783529A (en) * 1985-12-03 1988-11-08 Research Corporation Technologies Rapid synthesis of radiolabeled porphyrin complexes for medical application
US5162231A (en) * 1989-10-25 1992-11-10 Cole Dean A Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung
US4959356A (en) * 1989-05-26 1990-09-25 The United States Of America As Represented By The United States Department Of Energy Porphyrins for boron neutron capture therapy
FR2656866B1 (fr) * 1990-01-10 1992-05-15 Cis Bio Int Derives de porphyrine et metalloporphyrines eventuellement couples a une molecule biologiquement active, et composition pharmaceutique les contenant.
US5654423A (en) * 1990-11-21 1997-08-05 Regents Of The University Of California Boronated metalloporphyrine and therapeutic methods
US5149801A (en) * 1990-11-21 1992-09-22 The Regents Of The University Of California Boronated porphyrin compounds
US5312896A (en) * 1992-10-09 1994-05-17 Sri International Metal ion porphyrin-containing poly(imide)
DE4305523A1 (de) * 1993-02-17 1994-08-18 Diagnostikforschung Inst Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US5563132A (en) * 1994-06-21 1996-10-08 Bodaness; Richard S. Two-step cancer treatment method
US5648485A (en) * 1994-10-26 1997-07-15 University Of British Columbia β, β-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins
US5877165A (en) * 1995-11-02 1999-03-02 Brookhaven Science Associates Boronated porhyrins and methods for their use
US5955586A (en) * 1996-03-22 1999-09-21 Sessler; Jonathan L. Highly boronated derivatives of texaphyrins
WO1998030102A1 (en) * 1997-01-09 1998-07-16 Emory University Non-iron metalloporphyrins and methods of use
US6010805A (en) * 1998-05-26 2000-01-04 United States Of America As Represented By The Secretary Of The Air Force Ion conducting electrolyte material containing a lithium porphyrin complex
AU2001274827A1 (en) 2000-05-09 2001-11-20 The Regents Of The University Of California Porphyrin-based neutron capture agents for cancer therapy
US6566517B2 (en) * 2001-06-06 2003-05-20 Brookhaven Science Associates, Llc Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy
US7087214B2 (en) * 2002-02-01 2006-08-08 Zentaris Gmbh Water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
GB0222945D0 (en) * 2002-10-03 2002-11-13 Psimei Pharmaceuticals Plc Therapeutic compositions

Also Published As

Publication number Publication date
EP1753468A2 (en) 2007-02-21
WO2006088476A3 (en) 2006-12-21
JP2008505983A (ja) 2008-02-28
NZ551732A (en) 2011-03-31
CN1968705A (zh) 2007-05-23
EP1753468A4 (en) 2010-05-26
US6995260B2 (en) 2006-02-07
KR20070026552A (ko) 2007-03-08
AU2005327597A1 (en) 2006-08-24
US20050260128A1 (en) 2005-11-24
AU2005327597B2 (en) 2011-02-24
WO2006088476A2 (en) 2006-08-24
IL179497A0 (en) 2011-08-01
CA2567468A1 (en) 2006-08-24

Similar Documents

Publication Publication Date Title
NO20065858L (no) Karboranylforfyriner og anvendelser derav
WO2008133664A3 (en) Carboranylporphyrins and uses thereof
Ran et al. In vivo photoactivation without “light”: use of Cherenkov radiation to overcome the penetration limit of light
NO20070509L (no) Karboranylporfyriner og anvendelser derav
Haapaniemi et al. Boron neutron capture therapy in the treatment of recurrent laryngeal cancer
Wang et al. Dual key‐activated NIR‐I/II fluorescence probe for monitoring photodynamic and photothermal synergistic therapy efficacy
WO2008122056A3 (en) Medical apparatus and method associated therewith
ATE526037T1 (de) Verfahren zum abtöten von tumorzellen mittels targeting von auf apoptotischen tumorzellen exponierten internen antigenen
Kessel et al. Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome
Shliakhtsin et al. Pharmacokinetics and biodistribution of Photolon®(Fotolon®) in intact and tumor-bearing rats
WO2005041860A3 (en) Stem cells for use in locating and targeting tumor cells
De Salles et al. Stereotactic and microsurgery for acoustic neuroma: the controversy continues
Soucy-Faulkner et al. Copper-64 labeled sulfophthalocyanines for positron emission tomography (PET) imaging in tumor-bearing rats
Yu et al. BNCT treatment planning of recurrent head-and-neck cancer using THORplan
Thiagarajan et al. Sequential External Beam Radiotherapy and High–Dose‐Rate Intracavitary Brachytherapy in T1 and T2 Nasopharyngeal Carcinoma: An Evaluation of Long‐Term Outcome
Clark et al. Radiodynamic therapy as a potential strategy for metastatic control in small-cell lung cancer: a preclinical study
Chng Cancer in 2019–Progress and Challenges–A Perspective
Rey et al. Photodynamic therapy (PDT): Theoretical study of porphycene and azaporphycene electronic transitions
Munegowda et al. Neuro-Oncology Advances
Di Muzio et al. PO-0719: Excellent 5 year outcome with image guided moderate hypofractionation in prostate cancer: phase I-II study results
Sauer et al. Efficacy of radio-chemo-therapy with platin-derivatives compared to radiotherapy alone in organ sparing treatment of bladder cancer
Valentini Physics & Medicine: Toward a Future of Integration: Trento, November 6th–8th, 2014
Maslyakov et al. Changes of indicators of microcirculation at bazalnokletochny cancer of skin
Mcdonald ES16. 02 MRI-Based Radiotherapy
Wilkins et al. PO-0720: Patient reported outcomes of overall bowel and urinary bother in the CHHiP trial (CRUK: 8262/A7257)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application